ABSTRACT Twenty seven adults with cystic fibrosis who had had either a surgical pleurodesis or pleurectomy for the management of pneumothorax were studied. There were no significant differences in postoperative respiratory function, incidence of recurrent pneumothorax, or incidence of major postoperative complications between the two groups.
The natural history ofcystic fibrosis is complicated by a high incidence of pneumothorax, which increases with age; this constitutes an important cause ofmortality and morbidity.' Pleurodesis or pleurectomy is usually recommended ifthere is a persistent air leak after seven days' treatment with an intercostal drain or, in the event of a second symptomatic episode, after a short period of antibiotic treatment and intercostal drainage. Thoracotomy is safe even in the presence of severe airways obstruction' but it is not clear whether pleurodesis or pleurectomy constitutes the more satisfactory procedure for these patients.910 A review of our patients with cystic fibrosis submitted to surgical management of pneumothorax is presented in an attempt to clarify this issue.
Methods
The case notes of 27 patients with cystic fibrosis who underwent a thoracotomy for either pleurodesis or pleurectomy were reviewed. For comparison ofperioperative and postoperative data, patients were grouped according to whether they had had a pleurectomy or a pleurodesis.
The following details were abstracted from the case notes: (1) incidence of recurrent ipsilateral pneumothorax; (2) frequency of postoperative complications; (3) preoperative and postoperative respiratory function.
One patient who had had a resection of the right upper lobe at the time of pleurectomy was excluded from analysis. The preoperative data used were those recorded before the onset of the pneumothorax but not longer than a month before surgery.
Results
Of the 27 patients, nine had surgery to both pleural spaces. 
Discussion
Cystic fibrosis is characterised by progressive deterioration in pulmonary function. None of the 27 patients reviewed had a preoperative FEVY greater than 50% of the predicted value.
Three, six, and 12 months after operation there was no significant difference in FEV, or FVC between the group having pleurectomy and pleurodesis.
Increasing numbers of patients with cystic fibrosis in terminal respiratory failure are being successfully treated by heart-lung transplantation. One of the major problems faced by surgeons has been haemorrhage and difficulty in removing 
